Ipsen, grazie a ricerca, sviluppo e investimenti fatti notevoli passi aventi nel trattamento della spasticità post-ictus

(Adnkronos) - Patrizia Olivari (Ipsen): “Questo per migliore la qualità di vita delle persone che incontrano l’ictus e sviluppano una spasticità”

Transcript

00:00IBSEN has always been committed to neurosciences, as well as oncology and rare diseases.

00:10But in neurosciences in particular, we are working hard to respond to the needs of patients,

00:17and in particular in the post-ictus phases, thanks to our research and development

00:22and the investments we are making precisely to develop new and important therapeutic solutions

00:29in order to improve the quality of life of people who encounter ictus in their lives

00:35and who develop spasticity later.

00:40In addition to this, it is very important for us to continue to work in partnership

00:45with patient associations, scientific societies and institutions

00:50in order to guarantee a path that is the most suitable and appropriate,

00:54also multidisciplinary, in order to allow all patients

00:58to continue their lives as a normal life and with another degree of quality.

01:04In addition to this, we must also emphasize the importance of listening,

01:08because in order to bring solutions, there is a basic element that has always distinguished us,

01:13and it is really the listening of people who experience these difficulties,

01:17who experience post-ictus spasticity, because for us it is important to bring therapeutic solutions,

01:23but it is not just therapy, it is important to have a vision of togetherness

01:28with respect to the entire path that these patients live,

01:31they are not often alone, they are with their caregivers and therefore with their families.

01:35So, by listening to the experiences, we are bringing solutions,

01:40not only therapeutic, but also innovative.